Gabelli & Co Investment Advisers’s Acceleron Pharma XLRN Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,550	Closed	-$6.98M	–	534
2021 Q3	$6.98M	Buy	+40,550	New	+$5.3M	0.84%	31

Gabelli & Co Investment Advisers's XLRN Position: Q4 2021 in Review

Gabelli & Co Investment Advisers sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 40,550 shares — an estimated $6.98M sold.

Gabelli & Co Investment Advisers first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $6.98M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Gabelli & Co Investment Advisers reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 40,550 Acceleron Pharma shares in Q4 2021, an estimated $6.98M.
Gabelli & Co Investment Advisers first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Acceleron Pharma position peaked at $6.98M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2021, filed 11 Feb 2022.